KCC2 is a neuron-specific K + -Cl − co-transporter that maintains a low intracellular Cl − concentration that is essential for hyperpolarizing inhibition mediated by GABA A receptors. Deficits in KCC2 activity occur in disease states associated with pathophysiological glutamate release. However, the mechanisms by which elevated glutamate alters KCC2 function are unknown. The phosphorylation of KCC2 residue Ser940 is known to regulate its surface activity. We found that NMDA receptor activity and Ca 2+ influx caused the dephosphorylation of Ser940 in dissociated rat neurons, leading to a loss of KCC2 function that lasted longer than 20 min. Protein phosphatase 1 mediated the dephosphorylation events of Ser940 that coincided with a deficit in hyperpolarizing GABAergic inhibition resulting from the loss of KCC2 activity. Blocking dephosphorylation of Ser940 reduced the glutamate-induced downregulation of KCC2 and substantially improved the maintenance of hyperpolarizing GABAergic inhibition. Reducing the downregulation of KCC2 therefore has therapeutic potential in the treatment of neurological disorders.
a r t I C l e S The neuron-specific K + -Cl − co-transporter KCC2 constitutes the main extruder of Cl − in mature neurons. Maintenance of a low intracellular Cl − concentration is required for hyperpolarizing phasic and tonic inhibitory transmission mediated by Cl − -permeable GABA A and glycine receptors 1, 2 . Without KCC2, GABAergic and glycinergic signaling is limited to inhibitory shunting of membrane conductance or, conversely, to increased membrane excitability. Indeed, the early postnatal lethality of KCC2 knockout in mice highlights importance of KCC2 in neuronal function 3 .
The establishment of hyperpolarizing transmission follows the postnatal expression pattern of KCC2 (refs. 2,4,5) . In the adult CNS, depolarizing GABA A -mediated responses are observed primarily in pathophysiological conditions 6, 7 . A reduction of KCC2 expression and altered Cl − homeostasis occurs in several models of neuropathic pain [8] [9] [10] [11] [12] and ischemic brain injury [13] [14] [15] . Consistent with these observations, GABA A receptor agonists and positive allosteric modulators are initially neuroprotective, but rapidly lose efficacy after ischemic injury 16, 17 , whereas delayed administration of a negative allosteric modulator improves motor deficits after stroke in mice 18 . KCC2 function is also decreased by seizures in animals [19] [20] [21] . Specific neurons in the subiculum of human epileptic brain tissue exhibit depolarizing GABA responses 22 , which are attributable to decreased KCC2 expression 23 . The loss of KCC2 function could underlie the lack of therapeutic efficacy of common antiepileptic drugs in the treatment of temporal lobe epilepsy 24, 25 .
Mounting evidence indicates that phosphorylation of KCC2 dynamically regulates its activity and surface expression. Wnk3 kinase phosphorylation reduces KCC2 activity and causes a deficit in cell volume regulation 26 , and Wnk1 phosphorylation decreases transporter activity 27 . Inhibition of tyrosine activity also decreases KCC2 activity and disrupts surface clustering 28 . Tyrosine phosphorylation is correlated with decreased KCC2 activity and expression in models of oxidative stress and hyperexcitability 29 . We recently reported that tyrosine phosphorylation by Src-family kinase promotes lysozomal degradation of KCC2 in an epilepsy model 30 . We also found that KCC2 is directly phosphorylated by Ca 2+ /phospholipid-dependent protein kinase C (PKC) at residue Ser940 in the C-terminal intracellular domain, leading to enhanced KCC2 activity and reduced endocytosis 31 . However, the role of Ser940 phosphorylation in pathophysiological states is unknown.
Given the role of KCC2 in health and disease, understanding the cellular mechanisms that control its functional expression is of particular importance. Intrahippocampal microdialysis measurements reveal a sharp increase in ambient glutamate before and during seizures in conscious humans who have complex partial seizures 32 , and glutamate causes a depolarizing shift in the reversal potential of GABA-activated currents (E GABA ) by unknown mechanisms 33 . We hypothesized that pathophysiological levels of extracellular glutamate cause dephosphorylation of Ser940, leading to downregulation of KCC2 and altered GABAergic responses. Our results indicate that NMDA receptor activation and Ca 2+ influx induce rapid protein phosphatase 1 (PP1)-dependent dephosphorylation of Ser940 and downregulation of KCC2. This process was ameliorated by the phosphatase inhibitor okadaic acid (OKA). Dephosphorylation of Ser940 and its subsequent degradation therefore underlie the reduced KCC2 functional expression observed in pathophysiological states associated with elevated glutamate.
RESULTS

GABA depolarizes neurons after glutamate exposure
The neurotransmitter GABA adopts its canonical role as an inhibitor of neuronal excitability on upregulation of KCC2 in mature neurons 5 . KCC2 maintains a low intracellular concentration of Cl − and sets a r t I C l e S E GABA below the resting membrane potential (E M ), thereby enabling a GABA A -mediated Cl − influx that hyperpolarizes the membrane potential. We therefore used the gramicidin perforated patch-clamp technique to preserve the endogenous intracellular Cl − concentration. We began each experiment by establishing that neurons could sustain a hyperpolarizing response to repeated exposures of exogenous GABA. In our experiments on 14-21 d in vitro (DIV) dissociated hippocampal neurons, approximately 25% of the neurons exhibited depolarizing GABA responses at the beginning of the experiments and were discarded (see Online Methods for rationale). In voltage follower (I = 0) recording mode, GABA application hyperpolarized the membrane potential, indicating that E GABA is less than E M , which we attributed to functional expression of KCC2 ( Fig. 1a) . Indeed, application of the loop diuretic furosemide dissipated the hyperpolarizing responses to GABA until they became purely shunting, that is, furosemide positively shifted E GABA to values equal to E M ( Fig. 1b) . Consistent with our results, furosemide application to rodent brain slices shifts E GABA to more positive values 34, 35 . The dissipation of the ionic gradient varied greatly in time (9 ± 5 min, n = 4) and depended on both the furosemide inhibition of KCC2 function and the concurrent GABA A -mediated Cl − loading. In sharp contrast, the neurons quickly, and with far less variability (4 ± 1 min), reestablished a sustained hyperpolarizing GABA response after washout of furosemide ( Fig. 1c) .
In a separate set of recordings performed in the presence of the ionotropic glutamate receptor antagonists d(−)-2-amino-5-phosphonovaleric acid (AP5) and 6,7-dinitroquinoxaline-2,3-dione (DNQX), neurons exhibited sustained hyperpolarizing responses to exogenous GABA and bicuculline-sensitive spontaneous inhibitory postsynaptic potentials ( Fig. 2a) . We then applied glutamate alone for 2 min to simulate the increased glutamate that is observed before and during epileptic events in human hippocampus 32 (Fig. 2b) . The glutamate application initially triggered a barrage of action potentials before causing a sustained depolarizing block. At the end of the glutamate application, neurons were rapidly exposed to AP5 and DNQX to allow recovery of initial E M values. Every neuron tested (n = 8) exhibited spontaneous excitatory postsynaptic potentials and fired action potentials that were completely blocked by bicuculline, indicating that E GABA was now greater than E M and that these action potentials were not the results of generalized hyperexcitability caused by an increased Na + conductance or elevated extracellular K + (Fig. 2c) 36 . Neurons fired 20 ± 11 action potentials during the first minute and this activity markedly increased in the second minute to 42 ± 10 spikes, before slowly decreasing and falling silent after 8 min (Fig. 2d) . The slow repolarization of the membrane potential and the concurrent voltage-dependent de-inactivation process of the Na V channels that mediate action potentials were the likeliest causes of the initial increase in action potential firing rate.
Glutamate application causes a sustained depolarization of E GABA 33 . However, using voltage-ramp protocols to determine E GABA can either load or drain the neuron of Cl − depending on the direction (positive or negative) of the ramp procedure. To circumvent these possible artifacts, we performed a series of experiments in I = 0 mode and examined the period of time that neurons maintained a depolarizing GABA response after exposure to glutamate. We performed these experiments in the presence of AP5, DNQX and tetrodotoxin (TTX) a r t I C l e S to minimize Cl − flux by endogenous GABAergic phasic signaling. We first established that neurons exhibited a sustained hyperpolarizing response to exogenous GABA before the 2-min glutamate pulse ( Fig. 2e) . We then waited 2 min to allow neurons to establish E M values in ±5 mV of their initial value and then applied GABA every 2 min over a 20-min period ( Fig. 2f) . Consistent with our measurements of action potentials, neurons exhibited their strongest depolarizing responses to GABA in the first 4 min after the glutamate application was terminated ( Fig. 2g) . Depolarizing GABA responses lasted for at least 20 min after the beginning of the glutamate pulse, indicating that neurons lost their ability to extrude Cl − beyond equilibrium concentrations for a prolonged period. Our data also suggested that the polarity shift and Cl − loading must have taken place during the relatively brief glutamate pulse. We tested whether GABA A receptors were responsible for the Cl − influx by co-applying glutamate with the GABA A antagonist bicuculline because a surge in GABA concentration occurs during seizures 32 . Indeed, bicuculline substantially reduced the initial amplitudes of the depolarizing GABA responses after glutamate exposure (P < 0.05; Fig. 2g ). However, bicuculline neither protected the Cl − extruding mechanism nor abolished the depolarizing responses, indicating that there are multiple sources of Cl − influx during the glutamate pulse.
Glutamate induced a positive shift in E GABA We performed a series of experiments in both I = 0 and voltage-clamp modes to quantify the effects of glutamate on E GABA values. We first established that neurons exhibited sustained hyperpolarizing GABA responses and then performed steady-state current-voltage (I-V) relationships to estimate E GABA (Fig. 3a,b) . We constructed I-V plots and used linear regression analysis to extrapolate E GABA , which ranged between −60 and −96 mV, with an average E GABA of −79 ± 2 mV (n = 22; Fig. 3c ). These neurons had an average E M of −65 ± 2 mV, with values ranging between −50 and −77 mV, which yields an average driving force value on GABA-activated currents (DF GABA = E GABA -E M ) of −14 ± 3 mV, indicating these neurons possessed a dominant Cl − extruding mechanism ( Supplementary Fig. 1a ).
On the same set of neurons, we then applied glutamate alone for 2 min and allowed the neurons to recover for 8 min before assessing changes in GABA responses. Membrane potential measurements revealed that GABA application caused a sustained depolarizing response in 16 of the 22 cells that we tested, indicating that E GABA shifted to values greater than E M , and the membrane response was purely shunting in 4 of 22 neurons (Fig. 3a) . However, 2 of 22 neurons retained KCC2 function and hyperpolarizing GABA responses. Further analysis revealed that glutamate application significantly increased the extrapolated E GABA values by 27 ± 3 mV to −52 ± 3 mV (P < 0.001, paired t test; Supplementary Fig. 1b ) and caused a prominent rightward shift in the average I-V relationship (Fig. 3d) . After the glutamate application, the neurons exhibited E M values ranging between −51 and −82 mV, with an average of −63 ± 2 mV, yielding an average DF GABA value of 10 ± 3 mV ( Supplementary Fig. 1a ).
Glutamate altered the phosphorylation of KCC2 residue Ser940
It is now thought that membrane trafficking and activity of KCC2 is subject to regulation by phosphorylation [26] [27] [28] [29] [30] [31] . We focused on changes in the phosphorylation of Ser940 because PKC-dependent phosphorylation of this residue both enhances KCC2 activity and increases cell surface stability by reducing endocytosis 31 . We raised a phosphoantibody to a synthetic peptide containing Ser940 to specifically analyze its phosphorylation. We first characterized the specificity of phospho-Ser940 (pSer940) using recombinant KCC2 expressed in HEK-293 cells. Activation of PKC by the phorbol ester PDBu significantly increased pSer940 immunoreactivity in cells transfected with wild-type KCC2 (P < 0.01), whereas no signal was detected in cells expressing a KCC2 construct in which Ser940 was mutated to alanine ( Supplementary  Fig. 2a ). We then used a His-tagged fusion protein of the C-terminal intracellular domain of KCC2 (His-C) that is phosphorylated in vitro by PKC at residue Ser940 (ref. 31 ). pSer940 recognized the phosphorylated form of His-C, but not the dephosphorylated form ( Supplementary  Fig. 2b) . PDBu increased the phosphorylation of cell surface KCC2 in biotinylation assays performed on hippocampal neurons, and this effect was blocked by the PKC inhibitor calphostin C ( Supplementary  Fig. 2b,c) . Finally, pre-adsorption with the phosphorylated, but not dephosphorylated, antigen or pretreatment of the membrane with λphosphatase abolished pSer940 immunoreactivity ( Supplementary  Fig. 2d ). These results indicate that pSer940 detects KCC2 only when phosphorylated on Ser940.
Subsequent analyses revealed that dephosphorylation of Ser940 occurred rapidly after glutamate treatment. pSer940 immunoreactivity and total KCC2 protein were significantly reduced to 48 ± 10 and 58 ± 9% of control values (P < 0.01, n = 3) 15 min after glutamate application, respectively ( Fig. 4a and Supplementary Fig. 3 ). We also calculated the ratio of signal for pSer940/KCC2, which indicated that the reduced pSer940 immunoreactivity is a result of dephosphorylation rather than degradation of total KCC2. We then examined changes in surface expression, as phosphorylation of Ser940 slows a r t I C l e S the rate of endocytosis 31 . Biotinylation assays revealed that glutamate reduced cell surface KCC2 to 42 ± 6% of control values (Fig. 4b) .
Although this marked reduction in surface KCC2 explains the loss of hyperpolarizing GABA responses, the remaining population of surface KCC2 was most likely responsible for the progressive decrease in the amplitudes of the depolarizing GABA responses (Fig. 2f,g) .
NKCC1 did not mediate the large positive shift in E GABA GABA is the primary excitatory neurotransmitter in the immature brain. The Na-K-Cl co-transporter NKCC1 maintains the depolarizing effects of GABA by pumping Cl − into the cell and sets E GABA to values greater than E M . However, temporal changes in its expression patterns as the brain matures remain controversial 5, 6, 37 . Notably, the results of our bicuculline experiments suggest the presence of an additional source of Cl − influx that persisted throughout the experiment, indicating that an ion pump is involved. We therefore used the NKCC1-specific inhibitor bumetanide to examine the role of NKCC1 in the glutamate-induced shift in E GABA . We added bumetanide (10 µM) to all solutions to prevent rapid recovery of NKCC1 activity. Prior to glutamate application, GABA hyperpolarized the membrane potential and GABA-activated currents reversed at −83 ± 4 mV (n = 9; Supplementary Fig. 4a,b) . After glutamate exposure, the average E GABA value was significantly shifted by 22 ± 5 mV to a value of −61 ± 5 mV (P < 0.01, paired t test; Supplementary Figs. 1b and 4c) . This large shift in E GABA was not significantly less than that observed in the absence of bumetanide (P > 0.05). After glutamate exposure, neurons had an average E M value of −57 ± 2 mV, yielding an average DF GABA value of −4 ± 5 mV (Supplementary Fig. 1a ). The change in DF GABA was statistically different from the shift observed in the absence of bumetanide (P < 0.05). These data indicate that the combination of bumetanide and glutamate acted to shift E GABA to an averaged shunting level. GABA responses became depolarizing in only three of nine neurons, whereas four of nine retained hyperpolarizing responses and two of nine neurons exhibited a purely shunting response to GABA.
These results indicate that NKCC1 activity supports the sustained depolarizing GABA responses in some neurons 23 , but does not mediate the large glutamate-induced shift in E GABA .
To support our electrophysiological experiments, we measured the expression of NKCC1 in cultured neurons after glutamate treatment. Consistent with our results with bumetanide, the expression levels of NKCC1 were not modified on exposure to glutamate ( Supplementary  Fig. 4d) . These results indicate that glutamate-induced shifts in E GABA are largely caused by the loss of KCC2 function and are minimally dependent on NKCC1. However, it should be noted that our selection of only those neurons with hyperpolarizing GABA responses favored the examination of cells exhibiting a dominant Cl − extruding mechanism and presumably less influence of NKCC1.
Effects of glutamate are Ca 2+ and NMDA receptor dependent Deficits caused by glutamate are often associated with increased intracellular Ca 2+ . We therefore examined the role of extracellular Ca 2+ in the glutamate-induced shift in E GABA by co-applying the Ca 2+ chelator EDTA with glutamate. GABA application initially elicited sustained hyperpolarizing membrane potentials, and neurons exhibited E GABA values ranging between −60 and −86 mV, with an average value of −75 ± 4 mV (n = 7, Fig. 5a,b) . Co-application of glutamate (a) Cultured neurons were treated with 20 µM glutamate before immunoblotting with pS940 and KCC2 antibodies. The ratio of pS940:KCC2 immunoreactivity and total KCC2 levels were then determined. Con, control; Glu, glutamate. Full-length blots are provided in Supplementary  Figure 3 . Total KCC2 Tubulin a r t I C l e S and EDTA prevented the loss of hyperpolarizing GABA responses on six of the seven neurons tested, with one neuron exhibiting a purely shunting response (Fig. 5a) . Furthermore, EDTA reduced the large shift in E GABA , with an average value of −67 ± 2 mV after glutamate treatment (Fig. 5b,c) . In some instances, the glutamate treatment was without effect on E GABA , resulting in nearly superimposed average I-V relationships and an insignificant shift in E GABA (8 ± 3 mV, n = 7, P > 0.05, paired t test). Neurons exhibited average E M values of −56 ± 2 mV and DF GABA values of −19 ± 4 mV before, and E M values of −56 ± 2 mV and DF GABA values of −10 ± 2 mV after glutamate application (Supplementary Fig. 1) . We then evaluated the role of Ca 2+ in the glutamate-induced dephosphorylation and degradation of KCC2 by incubating neurons in the presence of EDTA for 15 min before the glutamate treatment. We found that EDTA pretreatment reduced the glutamate-induced dephosphorylation of Ser940 and degradation of total KCC2, indicating that Ca 2+ influx was necessary for dephosphorylation of Ser940 and degradation of KCC2 (Fig. 5d) . We next examined the role of the Ca 2+ -permeable NMDA receptor in this process by co-application of the NMDA receptor antagonist AP5 with glutamate. Membrane potential measurements recorded before and after glutamate treatment revealed that AP5 prevented the loss of hyperpolarizing responses to GABA in seven of the nine neurons tested, whereas only two neurons exhibited depolarizing responses (Fig. 6a) . I-V experiments performed before and after glutamate treatment revealed that co-application of glutamate and AP5 caused a significant, but much smaller, shift in E GABA , from −88 ± 4 mV to −72 ± 5 mV (P < 0. 01, paired t test; Fig. 6b,c and  Supplementary Fig. 1) . Neurons exhibited averaged E M values of −60 ± 2 mV and −58 ± 2 mV and averaged DF GABA values of −18 ± 4 mV and −8 ± 4 mV before and after glutamate treatment, respectively (Supplementary Fig. 1a ). We conducted biochemical assays and found that application of AP5 minimized the glutamate-induced reduction of cell surface KCC2, dephosphorylation of Ser940 and degradation of total KCC2 (Fig. 6d) .
OKA reduced the effects of glutamate on KCC2
The dephosphorylation of serine/threonine residues is mediated by specific protein phosphatases, including PP1, PP2A and PP2B 38 . We employed specific pharmacological agents to inhibit endogenous phosphatase activities to determine which phosphatase(s) a r t I C l e S was responsible for dephosphorylation of Ser940. For this experiment, we exposed neurons to OKA, which inhibits PP1/PP2A, or to cyclosporine A, which primarily inhibits PP2B 38 . Treatment of cultured neurons with OKA significantly increased phosphorylation of Ser940 to 192 ± 21% of control (P < 0.01), whereas cyclosporine A had no effect (Fig. 7a) . This result suggested that dephosphorylation of Ser940 was carried out by PP1 or PP2A. To further distinguish between these closely related phosphatases, we monitored the level of Ser940 phosphorylation with increasing concentrations of OKA. We determined that phosphorylation of Ser940 occurred at an OKA concentration greater than 100 nM, with a potency of 481 nM (Fig. 7b) .
Together, these results suggest that PP1 dephosphorylates KCC2 residue Ser940. We then evaluated the effects of inhibiting PP1 on the glutamate-induced dephosphorylation of KCC2 by pretreating neurons with OKA 15 min before the administration of glutamate. Pretreatment with OKA minimized the glutamate-induced reduction of cell surface KCC2, dephosphorylation of Ser940 and degradation of total KCC2 protein ( Fig. 7c) .
To support our biochemical analysis, we asked whether OKA could minimize the loss of functional KCC2 and maintain hyperpolarizing GABA responses. We examined E GABA and GABA-activated potentials before and after glutamate exposure on neurons that were pretreated with OKA for 10 min after establishing the perforated-patch configuration. OKA was also added to the GABA-and glutamate-containing solutions to maintain the inhibition of phosphatase activity throughout the recording period. Neurons exhibited sustained hyperpolarizing responses to GABA and E GABA values ranged between −72 and −97 mV, with an average value of −86 ± 4 mV (n = 7; Fig. 8a,b) . Steady-state I-V relationships revealed that OKA reduced the large shift in the average E GABA value after treatment with glutamate ( Fig. 8c  and Supplementary Fig. 1) . Neurons exhibited an average E GABA value of −75 ± 5 mV (Fig. 8b) . Although glutamate still caused a statistically significant shift in E GABA , as assessed by a paired t test (P < 0.01), the average glutamate-induced shift of 11 ± 3 mV was significantly less (P < 0.05) than that produced in the absence of OKA (Supplementary Fig. 1b ). In addition, GABA-activated potentials remained hyperpolarizing after glutamate treatment on five of seven neurons tested, whereas GABA depolarized only two neurons (Fig. 8a) . Neurons exhibited averaged E M values of −66 ± 2 mV and −62 ± 2 mV and averaged DF GABA values of −21 ± 4 mV and −12 ± 5 mV before and after glutamate treatment, respectively (Supplementary Fig. 1a) . As a control, we applied the vehicle DMSO (0.1%) to a separate set of neurons for 30 min and found no significant shift in E GABA values (−77 ± 5 mV before and −76 ± 1 mV after 30 min, n = 3, P > 0.05, paired t test) or membrane potential responses over this period (Fig. 2g) . Together, these results indicate that inhibition of PP1 activity by OKA pretreatment can reduce the functional loss of KCC2 caused by glutamate.
DISCUSSION
We describe for the first time, to the best of our knowledge, a cellular mechanism by which elevation of ambient glutamate downregulates KCC2 and abolish hyperpolarizing GABAergic transmission. We used biochemical and electrophysiological analyses of cultured rat hippocampal neurons to study KCC2 and determined that the glutamate-induced loss of KCC2 function involves a molecular pathway beginning with NMDA receptor activation and Ca 2+ influx that ultimately causes PP1-mediated dephosphorylation of KCC2 residue Ser940.
Cl − homeostatic mechanisms are the primary determinants of the ion conduction properties of GABA A and glycine receptors. Although the mechanism of action and roles of the ClC channels in the brain are becoming increasingly clear 39, 40 , the best characterized effectors of the Cl − distribution at rest in the CNS are NKCC1 and KCC2. Our data suggest that the role of KCC2 is to maintain hyperpolarizing GABA responses and that, after the glutamate-induced loss of KCC2 function, NKCC1 acts to maintain depolarizing GABA responses. As a result of our method of applying bath saline containing low concentrations of K + , it is highly unlikely that KCC2 reversed its directionality and contributed to Cl − loading, but this process could occur in vivo or in acute brain slices in which solution exchange is not as rapid 41 . Although our experiments were performed only on neurons exhibiting an adult-like dominant influence of KCC2, 14-21 DIV neurons are not adult neurons. Neurons become less plastic as they mature and could begin to express proteins that weaken or strengthen the surface stability of KCC2. Nevertheless, in our experiments, pathophysiological levels of glutamate induced the selective disruption of the Cl − homeostatic mechanism such that Cl − -permeable GABA A receptors depolarized neurons.
We previously found that PKC phosphorylates residue Ser940, thereby increasing both the amount and activity of KCC2 on the neuronal surface 31 . Group I metabotropic glutamate receptor (mGluR1) agonists shift E GABA to more hyperpolarized potentials 42 , likely by activation of PKC. It is possible that mGluR1 activation of PKC was overwhelmed in our experiments by the Ca 2+ effect on PP1 activity. Our data is consistent with and explains previous findings that elevation of glutamate causes a lasting depolarizing shift in E GABA values 33 . It might be expected that blockade of NMDA receptor activity would isolate the mGluR1 activation of PKC and cause a hyperpolarizing shift in E GABA . However, comparison of our AP5 and EDTA data suggest that other sources of Ca 2+ , such as L-type voltage-gated Ca 2+ channels and intracellular stores, could balance out PKC-dependent phosphorylation of Ser940. Despite these other possible sources of Ca 2+ , blockade of NMDA receptor activity accounted for the majority of the glutamate-induced shift in E GABA values and improved the maintenance of hyperpolarizing GABA responses from nearly 10% to greater than 75% of the neurons that we tested. a r t I C l e S We propose a dynamic phosphorylation-dependent mechanism controlled by the balance between PKC and PP1 activity at residue Ser940 that regulates the functional expression of KCC2. The efficiency of this regulatory process is important given the high turnover rate of cell-surface KCC2 and its dependence on clathrin-mediated endocytosis 21, 30, 31 . In our experiments, we observed a downregulation of surface KCC2 and a concurrent loss of hyperpolarizing GABAergic responses in a matter of minutes after glutamate exposure.
Excessive glutamate release after neuronal damage is well known 16 . Axonal damage causes a downregulation of KCC2 and a loss of hyperpolarizing GABAergic signaling 43, 44 . KCC2 protein and expression levels also decrease after ischemic insults [13] [14] [15] and victims of stroke have a higher susceptibility to seizures after the neurological insult 45, 46 . Similarly, glutamate is elevated in sclerotic human epileptic brain tissue 32, 47 and KCC2 function is reduced in both human and animal models of epilepsy 23, 48 . The pilocarpine model of epileptiform activity is associated with neuronal death in rat hippocampus and results in a depolarizing shift of E GABA and a reduction in total KCC2 protein that lasts weeks 20 . We recently reported that muscarinic receptor activation and pilocarpine-induced seizures in mice result in the phosphorylation of KCC2 residues Tyr903 and Tyr1087 and its degradation 30 . Brief periods of kindling-induced seizures in rats that are not associated with extensive neuronal damage cause a reduction in the expression of KCC2 that correlates with higher endogenous BDNF/TrkB receptor signaling and the release of Ca 2+ from intracellular stores 49 . Together with our present findings, these data suggest that the loss of KCC2 function is highly correlated with pathophysiological levels of ambient glutamate and Ca 2+ flux in several disease states.
Our results indicated that KCC2 function is dynamically regulated by balancing the activation of specific protein kinases and phosphatases. Given that isoforms of these phosphatases and kinases are differentially expressed among specific neuronal subtypes and circuits, it is likely that certain neurons are more prone to glutamateinduced loss of KCC2 function. Indeed, our findings reveal that a small percentage of rat hippocampal neurons retain KCC2 function after exposure to glutamate. It is therefore possible that the susceptibility to compromised GABAergic signaling could underlie the etiology and therapeutic profiles of specific types of epilepsy. Our research also highlights KCC2 as a possible therapeutic target. The development of pharmacological agents that can restore KCC2 function by blocking its endocytosis and degradation could represent a new clinical strategy.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
